Not much of a poster here in recent years, but have been in DXB since 2016.
The inconclusive result in DKD the Phase 2 trial in 2020 was a disappointment (more a frustration since it might well have been the result of DMX-200 providing unexpected residual benefit post dosing). Dimerix took this in its stride - DKD on the backburner and full steam ahead with FSGS.
Now we are at another inflection point: if the current trial results are positive and the FDA approves Phase 3, we could see a step change in Dimerix - not only running the FSGS trial, but also having the resources to revisit DKD and maybe even start pre-clinical work on DMX-700. DKD itself is a huge potential market.
- Forums
- ASX - By Stock
- DXB
- Dimerix (ASX: DXB) Discussion Thread
Dimerix (ASX: DXB) Discussion Thread, page-516
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
43.0¢ |
Change
-0.020(4.44%) |
Mkt cap ! $236.7M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 41.8¢ | $972.5K | 2.277M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 92116 | 42.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 57364 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 92116 | 0.425 |
8 | 150844 | 0.420 |
3 | 49247 | 0.415 |
7 | 183309 | 0.410 |
7 | 174830 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 57364 | 3 |
0.435 | 16690 | 1 |
0.440 | 27754 | 2 |
0.445 | 191221 | 3 |
0.450 | 93130 | 2 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |